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Background  and  purpose      Parathyroid  hormone  (PTH)  has 
attracted considerable interest as a bone anabolic agent. Recently, 
it has been suggested that PTH can also enhance bone repair after 
fracture and distraction osteogenesis. We analyzed bone density 
and strength of the newly regenerated mineralized tissue after 
intermittent  treatment  with  PTH  in  rabbits,  which  undergo 
Haversian bone remodeling similar to that in humans. 
Methods   72 New Zealand White rabbits underwent tibial mid-
diaphyseal osteotomy and the callus was distracted 1 mm/day for 
10 days. The rabbits were divided into 3 groups, which received 
injections of PTH 25 µg/kg/day for 30 days, saline for 10 days and 
PTH 25 µg/kg/day for 20 days, or saline for 30 days. At the end of 
the study, the rabbits were killed and the bone density was evalu-
ated with DEXA. The mechanical bone strength was determined 
by use of a 3-point bending test. 
Results   In the 2 PTH-treated groups the regenerate callus ulti-
mate load was 33% and 30% higher, absorbed energy was 100% 
and 65% higher, BMC was 61% and 60% higher, and callus tissue 
volume was 179% and 197% higher than for the control group. 
Interpretation   We found that treatment with PTH during dis-
traction osteogenesis resulted in substantially higher mineralized 
tissue volume, mineral content, and bending strength. This sug-
gests that treatment with PTH may benefit new bone formation 
during distraction osteogenesis and could form a basis for clinical 
application of this therapy in humans.  

 
Parathyroid  hormone  (PTH)  is  a  major  regulator  of  bone 
metabolism. It is a multifunctional molecule, with a unique 
ability to affect the bone metabolism in either a catabolic or 
an anabolic way. Intermittently administered human PTH is 
a strong bone anabolic treatment regimen (Rubin et al. 2002, 
Hamann and Lane 2006). Recombinant human parathyroid 
hormone  (rhPTH)  and  recombinant  bioactive  fragments  of 
human PTH are emerging as a unique new class of treatment 
options for osteoporosis (Hamann and Lane 2006). At present, 
PTH is the most potent anabolic (as opposed to antiresorptive) 
agent available for clinical treatment of osteoporosis to reduce 
fracture risk (Hamann and Lane 2006).
Recent experiments with rats have demonstrated that treat-
ment  with  PTH  increases  the  mechanical  strength  and  the 
callus formation in normal healing fractures (Holzer et al. 1999, 
Andreassen et al. 1999, 2001, Alkhiary et al. 2005, Barnes et 
al. 2008). Furthermore, an increased density of regenerated 
bone and enhanced fixation of steel implants in rats have been 
shown after PTH treatment (Skripitz et al. 2000b, Skripitz and 
Aspenberg 2001). Our knowledge of the effects of intermittent 
PTH treatment on newly regenerating bone after distraction 
osteogenesis is very limited. Seebach et al. (2004) reported 
enhanced mechanical strength and density of new bone after 
distraction osteogenesis in rats. However, no information is 
available on the effects of intermittent PTH treatment on dis-
traction osteogenesis in a larger animal.
 The process of new bone formation is highly coordinated 
through  different  factors,  such  as  blood  supply,  cytokines, 
growth factors, stem cell availability, and physical stresses and 
strains. The tissue within the gap between distracted bone ends 
is pluripotent but all the factors that influence the differentia-
tion of the cells have not been fully determined. These undif-
ferentiated cells in the bone gap may be targets for mechani-
cal  or  biological  intervention  designed  to  promote  bone 
regeneration (Richards et al. 1999). PTH may be one of these 
biological factors, although the mechanism behind the ana-
bolic effect of intermittent PTH treatment is not understood. 
PTH enhances the activity and number of osteoblasts, which 
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form bone and produce and secret insulin-like growth factor 
I (IGF-I), which, together with other growth factors such as 
IGF-II and TGF-b-1, mediates bone growth and development 
(Watson et al. 1995). PTH changes the levels of expression 
of many hormones, cytokines, and growth factors (Rubin et 
al. 2002). Consequently, as osteoblasts are the principal cellu-
lar target of PTH, intermittent administration of PTH may be 
useful as a pharmacological stimulator of new bone formation 
during distraction osteogenesis.
Clinically, distraction osteogenesis is widely used for leg 
lengthening, for treatment of non-union fractures, to replace 
bone defects after tumor resections and infections, and for 
treatment of various structural deformities. In humans, the 
completed process of new bone formation and consolidation 
to a level where it has sufficient strength for weight bearing 
requires a period of months to years. Thus, the potential of 
PTH to enhance bone formation and thereby bone strength 
after distraction osteogenesis would be of benefit.
 Our hypothesis was that intermittently administered human 
PTH(1–34) would enhance bone mineral content, mechanical 
strength, and regenerated tissue volume after standardized dis-
traction osteogenesis in a rabbit model. 
Materials and methods
Animals
72 skeletally mature female New Zealand White rabbits, 6–8 
months old with a mean body weight of 3.96 (3.4–4.6) kg 
were used in the study. The animals were housed separately in 
standard cages in a temperature-controlled room (21 ± 2°C), 
with free access to food and water. General anesthesia was 
induced and maintained by administering 5 mL subcutane-
ously 20 min before the operation and 2 mL subcutaneously 
at the start of the operation of a mixture prepared from 20 
mL Ketamine (50 mg/mL), 2.5 ml Lidocaine (20 mg/mL), 1 
mL Acepromazin (10 mg/mL), and NaCl. The rabbits received 
postoperative pain management, which followed the approved 
protocol.  Antibiotics  were  not  used.  The  experiment  was 
approved by the Danish Committee on Animal Experimenta-
tion (no. 2002/561-501).
After the operation, the rabbits were randomly divided into 
3 groups. The animals in the first group (PTH) received a 
subcutaneous injection of 25 µg/kg PTH (human PTH(1–34) 
(Bachem, Bubendorf, Switzerland) dissolved in 0.5 M saline 
with 2% heat inactivated rabbit serum) on a daily basis during 
the lengthening and consolidation period (30 days). The ani-
mals in the second group (vehicle + PTH) were injected on 
a daily basis with vehicle during the lengthening period (10 
days) and with PTH (25 µg/kg/day) during the consolidation 
period (20 days). The animals in the third group received a 
corresponding injection of vehicle, and served as controls. 
The PTH dosage was selected based on the findings of a pilot 
study (Aleksyniene et al. 2006).
Surgical procedure and distraction protocol
The  standard  surgical  approach  and  a  distraction  protocol 
introduced by Schumacher et al. (1994) and later modified by 
Bundgaard (1999) was used. The right tibia was approached 
through a curved longitudinal skin incision. The fascia was 
cut, the muscles separated, and the anterior medial surface 
of the tibia was opened. The periosteum was incised longi-
tudinally  and  retracted.  4  holes  were  drilled  with  a  2-mm 
drill and self-taping screws (M300 or M301; Orthofix, Bus-
solenga, Italy) were inserted. The periosteum was protected 
and an osteotomy performed at the mid-diaphysis just below 
the tibiofibular junction between the second and third screws. 
A monolateral external fixator (Orthofix M100) was mounted. 
The periosteum and muscular fascia were then closed over 
the bone with interrupted sutures, and sutures were used to 
close the skin. Buprenorphinum (Temgesic) was given rou-
tinely as subcutaneous injections twice a day in order to con-
trol postoperative and lengthening-induced pain until 15 days 
after surgery, at a dose of 0.04 mg/kg after which the dose was 
gradually reduced to 0 over the following 3 days. The wound 
was observed daily for signs of infection. The animals were 
weight-bearing and mobile on the day of surgery. The distrac-
tion was started 5 days postoperatively at a rate of 1 mm/day 
(0.5 mm in 2 increments with at least 6 h between the incre-
ments) and continued for 10 days. Then a consolidation period 
of 20 days followed. Radiographs were taken under sedation 
5, 14, and 28 days postoperatively in order to monitor bone 
formation and the fixation of the distraction device (Figure 
1).
All animals were killed 5 weeks postoperatively with a bar-
biturate overdose given intravenously. The tibiae of both legs 
were disarticulated, dissected free, cleaned, radiographed in 2 
planes, and frozen at –20°C.
Figure 1. Radiograph taken during the consolidation period on day 
28 (PTH group) showing both periosteal and endosteal regenerate 
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Dual-energy X-ray absorptiometry (DEXA)
The right and left tibial bone specimens were scanned in a 
DEXA scanner (Norland Eclipse; Norland, Ft. Atkinson, WI) 
in a standard position with the posterior surface of the bone 
facing the scanner plate. The bone mineral content (BMC) and 
areal bone mineral density (BMD) were determined with 2 
regions of interest (ROIs) using the Small Subject program. 
Firstly, a 15-mm-long and 30-mm-wide “total ROI” was 
placed centrally between the second and third screw holes 
(marked  with  injection  needles),  which  included  approxi-
mately 2.5 mm of the proximal and approximately 2.5 mm 
of the distal old bone and the surrounding callus. Secondly, 
a 6-mm-long and 30-mm-wide “de novo ROI” was placed 
centrally in the regenerated callus. In addition, the BMD was 
measured at the mid-diaphysis of the intact contralateral tibia 
with the same size and approximate location as the “total ROI” 
of the distracted tibia.
Preparation of bone specimens
Subsequently, an approximately 40-mm-long bone specimen 
containing the regenerated callus was obtained from the dis-
tracted tibia by sawing between the first and second screw 
holes and between the third and fourth screw holes with a dia-
mond precision-parallel saw (Exakt Apparatebau GmbH, Nor-
derstedt, Germany) (Figure 2). In addition, a similar specimen 
was obtained from the contralateral tibia.
Bone volume and external callus dimensions
The  volume  of  the  bone  specimens  was  determined  using 
Archimedes’ principle by weighing the specimens before and 
during immersion in water on an electronic scale equipped to 
measure volumes. The total regenerate tissue volume was esti-
mated as the volume of the distracted 40-mm-long bone speci-
men minus the volume of the contralateral intact 40-mm-long 
bone specimen. The length of the tibial bone specimen and the 
distance between the second and third screw holes were deter-
mined with an electronic sliding calliper, and the midpoint of 
the bone specimen was marked with a waterproof marking 
pen. The distance between the second and third screw holes 
was considered to be an expression of the length gained during 
the distraction. In addition, the external anterior-posterior and 
medial-lateral diameters were measured with the sliding cal-
liper at the midpoint of the distraction regenerate callus.
 Before the destructive mechanical test, all bone specimens 
from the distracted tibiae were µCT scanned in order to inves-
tigate the effects of the PTH treatment on the microstructure 
of the regenerated mineralized tissue. The results of this inves-
tigation will be presented elsewhere.
Mechanics
The mechanical strength of the regenerated bone was deter-
mined by a 3-point bending test (Turner and Burr 1993) in 
a  materials-testing  machine  (Instron  5566;  Instron,  High 
Wycombe, UK). The bone specimens were placed with the 
posterior surface facing downwards on a custom-made testing 
jig constructed for 3-point bending. The distance between the 
supporting rods was fixed at 30 mm. Both distracted and intact 
tibial bone samples were tested at a constant deformation rate 
of 2 mm/min with the load applied at the midpoint of the bone 
specimen. During the 3-point bending test, load-deformation 
values were recorded using an attached PC and the software 
supplied with the materials testing machine. The load-defor-
mation data were subsequently analyzed using a custom-made 
computer  program  (Mosekilde  et  al.  1997). The  following 
parameters were calculated: ultimate load, Fmax (i.e. the maxi-
mum force that the specimens sustain), stiffness (the slope of 
the linear portion of the load-deformation curve), and work to 
failure (Wabs; the area under the load-deformation curve until 
failure). These measures are structural properties that depend 
on intrinsic material properties and on the geometry of the 
samples. The cross sections could not be assumed to be ellip-
tical and homogenous, and a simple estimation of the axial 
moment of inertia could thus not be performed. Consequently, 
the data were not normalized in order to estimate geometry-
independent material properties.
For the intact tibia, only the ultimate load is reported here 
whereas the other mechanical properties will be reported else-
where.
Statistics 
The statistical analysis was performed using Stata (Stata Cor-
poration, College Station, TX). Differences between groups 
were tested by analysis of variance (ANOVA) with a t-test for 
post-hoc analysis. Before the analysis, all data were tested for 
normal distribution and homogeneity of variances, and when 
these conditions were not fulfilled, the analysis was performed 
on logarithmically transformed data or using a Kruskal-Wallis 
test followed by a Wilcoxon-Mann-Whitney test for post-hoc 
Figure 2. Longitudinal sections of the bone specimens made after the 
mechanical testing procedure: A. PTH; B. control. Bar = 10 mm.
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analysis. As the final body weights differed statistically sig-
nificantly between the 2 PTH-treated groups and the control 
group, the analysis of mechanical test data was performed 
using  bone  strength  parameters  adjusted  to  the  final  body 
weight of the animal. Unless otherwise stated, the results are 
presented as means and 95% confidence intervals (95% CIs). 
The statistical method used is indicated in the tables. Differ-
ences were considered significant at p < 0.05.
Results
21 rabbits were excluded from the study: 18 had a tibial frac-
ture through one of the fixation screw holes, 2 died due to 
repeated anesthesia during radiographic examination, and 1 
died from unknown causes. In all, 51 of the 72 rabbits com-
pleted the study and were included in the analyses, with the 
following  group  distribution:  PTH,  19  animals;  vehicle  + 
PTH, 17 animals; and control, 15 animals. During the experi-
ment, there were no signs of infection except for a few mild 
delays in wound healing due to self-extraction of the opera-
tion  suture,  requiring  no  treatment. All  rabbits  lost  weight 
during the study, on average 365 (SD 199) g. The animals that 
received PTH lost 10% of their original weight, animals that 
received vehicle + PTH lost 11%, and the control animals lost 
7% (Table 1).
Radiographic follow-up provided a visual evaluation and 
monitoring  of  the  regenerate  tissue  formation.  Initiation 
of  both  periosteal  and  endosteal  calluses  at  the  bone  ends 
became apparent at the end of the lengthening period, i.e. 2 
weeks postoperatively (Oxlund et al. 1993). After having per-
formed a series of radiographs, we were able to observe callus 
progression on both sides towards the interfragmentary gap 
with the characteristic zone structure, i.e. a central radiolucent 
zone and two adjacent sclerotic zones (Yasui et al. 1993, Li et 
al. 2006). Moreover, in both PTH-treated groups the regener-
ate callus was visually denser and larger than in the control 
group.
The length gained during distraction was similar for all 3 
groups. The average of the indirect measurement of the length 
gained (the length between the second and third screw holes) 
was 28 (SD 0.6) mm in the PTH group, 28 (SD 0.86) mm in 
the vehicle + PTH group, and 27 (SD 0.84) mm in the con-
trol group. In all the animals, the tibia was lengthened by 
approximately 10 mm (approximately 10% of the initial tibial 
length). 
Regenerate tissue volume and external callus dimen-
sions (Table 2)
The animals in the 2 PTH-treated groups (PTH and vehicle 
+ PTH) had statistically significantly higher regenerate tissue 
volume  and  volume  of  the  mid-shaft  fragment,  including 
regenerated  callus  and  surrounding  bone,  than  the  control 
animals. The external regenerate callus dimensions were also 
statistically significantly higher in both PTH-treated groups 
than in the control group. However, for these parameters the 
differences between the two PTH-treated groups were not sta-
tistically significant.
Table 1. Animal body weight characteristics
    Mean (SD) [range]    p-value
Body  PTH  Vehicle + PTH   Control  ANOVA   PTH vs.  Vehicle+PTH  PTH vs. 
weight (g)  (n = 19)  (n = 17)   (n = 15)     Control   vs. Control  Vehicle+PTH 
Initial  3.94 (28) [3,500–4,450]  3,900 (304) [3,400–4,500]  4,063 (275) [3,500–4,600]  0.3   0.2   0.1   0.7
Final   3.55 (26) [3,150–3,950]  3,485 (295) [2,900–3,950]  3,787 (308) [3,200–4,300]  0.01   0.02   0.005   0.5
Table 2. Total regenerate callus volume and external callus dimension properties of the regenerated callus
   Mean (SD)    p-value
   PTH  Vehicle + PTH  Control  a ANOVA  PTH vs.   Vehicle+PTH   PTH vs. 
  (n = 19)  (n = 17)  (n = 15)  b Kruskal-Wallis  Control    vs. Control    vehicle+PTH
Volume (mm3)        
  Mid-diaphyseal 
     sample (40 mm)   4,030 (220)   4,129 (296)   2,536 (73)     < 0.001 b     < 0.001   < 0.001   0.8
     sample left (40 mm)   1,621 (27)   1,653 (37)   1,673 (31)       0.5 a     0.3     0.7   0.5
  Regenerated callus  2,408 (211)   2,557 (299)      862 (56)    < 0.001 b   < 0.001   < 0.001   0.9
Callus dimensions (mm)       
  Anterior-posterior (AP)   13.2 (0.5)   12.7 (0.6)   10.4 (0.3)    < 0.001 a   < 0.001      0.002   0.4
  Medial-lateral (ML)   13.4 (0.3)   13.3 (0.3)   11.1 (0.2)    < 0.001 a  < 0.001   < 0.001  0.9720  Acta Orthopaedica 2009; 80 (6): 716–723
Dual-energy X-ray absorptiometry (Table 3)
The PTH-treated animals had statistically significantly higher 
BMC and BMD of the regenerated tissue in both the “total 
ROI” and the “de novo ROI” than the control animals. The 
differences between PTH-treated and vehicle + PTH-treated 
animals were not statistically significant. At the contralateral 
intact tibia, the animals in the PTH group had statistically sig-
nificantly higher BMD than the control animals. In contrast, 
the animals in the vehicle + PTH group did not have statisti-
cally significantly higher BMD than the control animals.
Mechanics (Table 4 and Figure 3) 
The ultimate load of the regenerate mineralizing callus in the 
PTH-treated groups was 33% higher (PTH) and 30% higher 
(vehicle + PTH) than that of the control group (p = 0.001 in 
both cases). Similarly, the work to failure in the 2 PTH-treated 
Table 3. Bone mineral content (BMC) and bone mineral density (BMD) of the regenerated callus, and BMD of the contralateral intact tibia
  Mean (SD)    p-value
   PTH  Vehicle + PTH  Control  a ANOVA   PTH vs.   Vehicle+PTH   PTH vs.
  (n = 19)   (n = 17)   (n = 15)    b Kruskal-Wallis  Control    vs. Control    Vehicle+PTH
 
Total ROI        
  BMC (g)   0.91 (0.12)   0.9 (0.21)   0.59 (0.84)    < 0.001 a   < 0.001   < 0.001   0.7
  BMD (mg/cm2)    400 (40)    390 (70)    311 (40)    < 0.001 b   < 0.001   < 0.001   0.6
De novo ROI        
  BMC (g)    0.33 (0.05)   0.33 (0.09)   0.21 (0.04)    < 0.001 a   < 0.001   < 0.001   0.7
  BMD (mg/cm2)    370 (40)    360 (80)    270 (40)    < 0.001 b   < 0.001   < 0.001  0.6
Contralateral central ROI       
  BMD (mg/cm2)    314 (20)    300 (20)    290 (20)       0.01 a      0.004      0.3   0.05
Table 4. Results of the three-point bending test for the distracted tibia and the contralateral intact tibia. The analysis was performed using 
data adjusted to the final body weight of the animal (see the text for detail). Selected data are shown in Figure 3
   Mean (SD)    p-value, (95% CI for differences)
  PTH  Vehicle + PTH  Control  ANOVA  PTH vs.  Vehicle + PTH    PTH vs. 
  (n = 19)   (n = 17)  (n = 15)    Control  vs. Control  Vehicle + PTH
Distracted tibia        
 F max (N)   344 (29)  338 (40)  260 (27)  < 0.001  0.001 (-228 to -60)   0.001 (66 to 242)  0.9 (-67 to 88)
 W abs (mJ)  454 (112)  374 (112)  227 (101)   0.02   0.01  (-489 to -100)   0.02  (31 to 437)  0.5 (-240 – 119)
  Stiffness (N/mm)   283 (71)  269 (80)  250 (34)   0.2   0.3  (-141 to 19)   0.2  (-31 to 133)  0.8 (-83 to 63)
Intact contralateral tibia        
   Fmax (N)  491 (14)   453 (14)  449 (14)  0.005   0.004 (-100 to -20)  0.07  (-15 to 69)   0.2 (-70 to 3)
Figure 3. Box-and-whisker plots showing the results of the three-point bending test of the distracted tibia. 
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groups was 100% higher (PTH) and 65% higher (vehicle + 
PTH) than that of the control group (p = 0.01 and p = 0.02, 
respectively). In contrast, the ultimate load and the work to 
failure were not statistically significantly different between the 
2 PTH-treated groups. Furthermore, the stiffness of the min-
eralizing callus of the PTH-treated animals was 13% higher 
(PTH) and 8% higher (vehicle + PTH) than that of the control 
group, but these differences were not statistically significant. 
The ultimate load of the intact tibia was 10% higher in the 
PTH group than in the control group (p = 0.004) , whereas the 
ultimate load of the animals in the vehicle + PTH group was 
not statistically significantly different from that of the control 
group.
Discussion
We found that intermittently administered PTH augmented 
new mineralizing callus formation and development, resulting 
in increased regenerate callus size, volume, and bone mineral 
content. Moreover, the increased amount of new mineralized 
tissue resulted in an increase in ultimate load and work to fail-
ure of the regenerate callus in both PTH-treated groups com-
pared to the control group. 
To the best of our knowledge, only one experimental study 
has been conducted previously to investigate the effects of 
PTH on distraction osteogenesis (Seebach et al. 2004). That 
study was performed in rats, which have limited intracorti-
cal remodeling; it was therefore of interest to investigate the 
effects  of  PTH  on  distraction  osteogenesis  using  a  larger 
animal model with a cortical bone remodeling pattern more 
similar to that of human cortical bone. Rabbits have a short 
remodeling period compared to larger animals, they grow rap-
idly, and achieve early skeletal maturation (by 6–9 months) 
(Hirano et al. 1999). Previously, the effect of PTH on rabbits 
has only been investigated using intact bone (Hirano et al. 
1999, Mashiba et al. 2001), whereas no previous studies have 
evaluated the effects of PTH on distraction osteogenesis using 
a larger animal such as the rabbit.
The study by Seebach et al. (2004) indicated that after 20 
days of consolidation the ultimate load and the stiffness of the 
distracted bone were 50% higher in PTH-treated rats than in 
control rats. Furthermore, they showed that the total regener-
ate callus volume was 58% higher and the BMC and BMD 
of the distracted callus were 24% higher in PTH-treated rats 
than in control rats. Our findings in rabbits are consistent with 
their findings in rats, although we found that the regenerate 
callus BMC was approximately 60% higher in PTH-treated 
animals than in control animals. The effect of the PTH treat-
ment on the mechanical properties was less pronounced than 
in the rat study by Seebach et al. (2004). However, it is impor-
tant  to  note  that  the  rat  exhibits  a  stronger  bone-anabolic 
response to PTH than humans do (Li et al. 1999). As rabbits 
have a cortical bone remodeling pattern more similar to that 
of human bone than to that of rats, the anabolic response to 
PTH in rabbits would not be expected to be as prominent as 
in rats. In addition, our findings confirm the results of other 
studies showing substantial anabolic effects on newly form-
ing bone in different situations such as fracture healing, bone 
chamber studies, or titanium implant anchorage in low-den-
sity trabecular bone (Andreassen et al. 1999, Holzer et al. 
1999, Skripitz et al. 2000a, Skripitz and Aspenberg 2001, 
Gabet et al. 2006).
In the present study, we have analyzed mechanical strength 
parameters that represent extrinsic properties of bone such as 
ultimate load, energy absorption, and bone stiffness (Turner 
and Burr 1993). It was not possible to normalize the size-
dependent  mechanical  properties  to  geometry-independent 
mechanical properties, due to the irregular shape of the callus. 
However, the ultimate load and energy absorption are the most 
important measures in bone mechanics and provide good esti-
mates of clinically relevant mechanical properties (Eckardt 
2003). In PTH-treated animals, the ultimate load of the dis-
tracted tibia was 70–75% of the ultimate load of the intact 
contralateral tibia, whereas the ultimate load of the distracted 
tibia in control animals was only 58% of the ultimate load of 
the contralateral intact tibia. 
The anabolic effect of PTH could also be detected in the 
intact  contralateral  tibia,  but  to  a  lesser  extent  than  was 
observed in the distracted tibia. This supports the notion that 
PTH has a stronger effect on bone with an activated repair 
response than on bone undergoing normal remodeling (See-
bach et al. 2004, Skripitz et al. 2000b).
The DEXA data were investigated with 2 different ROIs in 
order to analyze the entire callus including old cortical bone 
(“total ROI”) and the newly regenerated mineralizing tissue 
(“de novo ROI”) separately. The BMC of the “total ROI” of 
the PTH-treated animals was almost 75% of that of the contra-
lateral intact tibia, whereas the BMC of the “total ROI” of the 
untreated control animals was only 15% of that of the contra-
lateral intact tibia. This clearly demonstrates that development 
of new calcified tissue at the distracted tibia is accelerated in 
PTH-treated animals.
We studied 2 different PTH treatment regimens in order to 
determine whether the effect of PTH treatment during length-
ening and consolidation differs from the effect of PTH treat-
ment during the consolidation period only. However, the bone 
parameters analyzed were similar for the 2 PTH treatment 
regimens. This is in accordance with the findings of Richards 
et al. (1999), who showed that the bone formation in the dis-
traction gap in rabbit bone was most active between 18 and 24 
days after the operation. Furthermore, they found an increase 
in mineralized new bone volume and an increase in BV/TV 
within the distraction gap, and observed regions of both intra-
membranous and endochondral bone formation early in the 
consolidation  period.  Consequently,  Richards  et  al.  (1999) 
suggested that interventions designed to enhance the bone for-
mation process should occur during this time window.722  Acta Orthopaedica 2009; 80 (6): 716–723
In addition, PTH may stimulate matrix synthesis and miner-
alization at early stages of the consolidation period, whereas 
the contribution of PTH to the very young immature pluripo-
tent tissue during the lengthening period remains question-
able. It is known that PTH also stimulates progenitor cell pro-
liferation and recruitment of bone lining cells (Thomas 2006), 
although our study does not demonstrate that treatment with 
PTH during both the lengthening and consolidation periods 
is superior to treatment with PTH during the consolidation 
period only. In contrast, in mature bone the anabolic effect 
of PTH is primarily determined by bone cells that are known 
to be direct targets of PTH, which line the trabecular surface 
(Dobning  et  al.  1995)—and  their  (re)activation  (Friedl  et 
al. 2007). Osteblasts are known to be direct targets of PTH 
(Thomas 2006). Thus, the anabolic effect of PTH on new min-
eralized tissue in the later stages of the consolidation period 
would be expected to be more pronounced than in the earlier 
stages. However, our results do not demonstrate any additional 
benefit from treatment with PTH during the distraction period, 
and therefore suggest that the stimulation of bone formation 
with PTH could be limited to the consolidation period. Fur-
ther studies are needed in order to investigate whether PTH 
treatment is needed for the entire duration of the consolidation 
period, or whether it could be limited to a shorter period. In 
humans, the consolidation period after distraction osteogen-
esis is time consuming since the maturation and consolidation 
of the regenerate callus typically requires a period that is 2–3 
times as long as the distraction period. Identification of the 
part of the consolidation period that would benefit most from 
the PTH treatment would be cost effective.
The  mechanical  properties  of  osseous  tissue  depend  on 
a  number  of  features,  which  may  influence  the  test  results 
(Paavolainen 1978). If the mechanical equipment used for mea-
surements is as precise as possible, biological variations may 
critically affect the results. Paavolainen (1978) showed that the 
rabbit body weight was correlated to the tibial maximum torque 
moment and energy absorption in a study on the healing of 
experimental fractures. Paavolainen (1978) therefore suggested 
that if the body weight of the animals differed, the torsional 
properties of whole bone specimens should be corrected for the 
weights of the animals, in order to arrive at comparable results. 
In our study, we observed that the animals lost approximately 
9% of their initial body weight. At the end of the experiment, 
the body weight of the rabbits in both PTH-treated groups was 
lower than in the control group. Although our mechanical test-
ing method was different from that of Paavolainen (1978), the 
parameters obtained in our study reflect similar bone strength 
characteristics and therefore the statistical analysis of mechani-
cal strength results was performed on data adjusted to the final 
body weight of the rabbits. 
Our findings indicate that intermittent human PTH treatment 
could be used for bone stimulation in orthopedic surgery, and 
that a positive anabolic effect of PTH on regenerate bone can 
be expected in humans.
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